Skip to content

Clinical trials

Recruiting Phase 1/2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Status: Recruiting Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20246
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital3
Princess Maxima Center for Pediatric Oncology3
Bambino Gesù Hospital and Research Institute1
Beijing Biotech1
Beijing Tongren Hospital1
Essen Biotech1
Gyala Therapeutics1
Otsuka Medical Devices Co., Ltd. Japan1
Peking University People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma13
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Recurrence5
Leukemia3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia, Myeloid, Acute2
Leukemia, T-Cell2
Lymphoma, T-Cell2
Blastic Plasmacytoid Dendritic Cell Neoplasm1
Burkitt Lymphoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.